1 |
Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome [J]. New Engl J Med, 2009, 360(12): 1226-1237.
|
2 |
Hervé D, Ibos-Augé N, Calvière L, et al. Predictors of clinical or cerebral lesion progression in adult moyamoya angiopathy [J]. Neurology, 2019, 93(4): 388-397.
|
3 |
Tho-Calvi SC, Thompson D, Saunders D, et al. Clinical features, course, and outcomes of a UK cohort of pediatric moyamoya [J]. Neurology, 2018, 90(9): 763-770.
|
4 |
Fujimura M, Bang OY, Kim JS. Moyamoya disease [J]. Front Neurol Neurosci, 2016, 40: 204-220.
|
5 |
Kang S, Liu X, Zhang D, et al. Natural course of moyamoya disease in patients with prior hemorrhagic stroke [J]. Stroke, 2019, 50(5): 1060-1066.
|
6 |
Takahashi JC, Funaki T, Houkin K, et al. Impact of cortical hemodynamic failure on both subsequent hemorrhagic stroke and effect of bypass surgery in hemorrhagic moyamoya disease: a supplementary analysis of the Japan Adult Moyamoya Trial [J]. J Neurosurg, 2020.Online ahead of print.
|
7 |
Kikuta K, Takagi Y, Nozaki K, et al. The presence of multiple microbleeds as a predictor of subsequent cerebral hemorrhage in patients with moyamoya disease [J]. Neurosurgery, 2008, 62(1): 104-111, discussion 111-102.
|
8 |
Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis) [J]. Neurol Med Chir (Tokyo), 2012, 52(5): 245-266.
|
9 |
Cordonnier C, Potter GM, Jackson CA, et al. Improving interrater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS) [J]. Stroke, 2009, 40(1): 94-99.
|
10 |
Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain [J]. Arch Neurol, 1969, 20(3): 288-299.
|
11 |
烟雾病和烟雾综合征诊断与治疗中国专家共识编写组, 国家卫生计生委脑卒中防治专家委员会缺血性卒中外科专业委员会. 烟雾病和烟雾综合征诊断与治疗中国专家共识(2017) [J]. 中华神经外科杂志, 2017, 33(6): 541-547.
|
12 |
Yin H, Liu X, Zhang D, et al. A novel staging system to evaluate cerebral hypoperfusion in patients with moyamoya disease [J]. Stroke, 2018, 49(12): 2837-2843.
|
13 |
Yamao Y, Takahashi JC, Funaki T, et al. Revascularization surgery in childhood associated with a low incidence of microbleeds in adult patients with moyamoya [J]. World Neurosurg, 2020, 133: e716-e721.
|
14 |
Kikuta K, Takagi Y, Nozaki K, et al. Histological analysis of microbleed after surgical resection in a patient with moyamoya disease [J]. Neurol Med Chir (Tokyo), 2007, 47(12): 564-567.
|
15 |
Miyamoto S, Yoshimoto T, Hashimoto N, et al. Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial [J]. Stroke, 2014, 45(5): 1415-1421.
|
16 |
Wenz H, Wenz R, Maros M, et al. Incidence, locations, and longitudinal course of cerebral microbleeds in European moyamoya [J]. Stroke, 2017, 48(2): 307-313.
|
17 |
Qin Y, Ogawa T, Fujii S, et al. High incidence of asymptomatic cerebral microbleeds in patients with hemorrhagic onset-type moyamoya disease: a phase-sensitive MRI study and meta-analysis [J]. Acta Radiol, 2015, 56(3): 329-338.
|